PLTR vs WST · P/E 584, rev $4.48B vs P/E 35, rev $2.89B
Palantir Technologies Inc. Class A Common Stock (PLTR) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the PLTR and WST stock pages for the full models.
Not investment advice.